comparemela.com

Erin Skeens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OncoOne Presents Preclinical Proof of Concept Data for its Next-Generation oxMIF-targeted Monoclonal Antibody ON203 at the AACR Annual Meeting | Antibodies

OncoOne Presents Preclinical Proof of Concept Data for its Next-Generation oxMIF-targeted Monoclonal Antibody ON203 at the AACR Annual Meeting

New orleansUnited statesErin skeensRandolf kerschbaumerAlexander schinaglAmerican association for cancer researchOncoone presents preclinical proofConcept dataMonoclonal antibodyAustriai aprilAmerican associationCancer researchAnnual meetingCell pressTherapeutic antibodiesAntibody drug conjugates

OncoOne Presents Preclinical Proof of Concept Data for its Next-Generation oxMIF-targeted Monoclonal Antibody ON203 at the AACR Annual Meeting

OncoOne, a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the presentation of preclinical proof-of-concept data on its lead candidate

New orleansUnited statesErin skeensKostenloser wertpapierhandelRandolf kerschbaumerDesmond jamesAlexander schinaglAmerican association for cancer researchTrophic communicationsAmerican associationCancer researchAnnual meetingCell pressMedia inquiries

vimarsana © 2020. All Rights Reserved.